Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18-70 years old; 2. After neoadjuvant chemotherapy, breast cancer surgery, esophageal cancer surgery, ovarian cancer surgery, gastric cancer surgery, colon cancer surgery, lung cancer surgery; 3. Elective surgery; 4. Informed consent was obtained from patients or their family member Subtopic 1: Clinical study on perioperative rapid recovery of patients undergoing surgery after neoadjuvant chemotherapy for breast cancer using Shengmai decoction: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, breast cancer surgery is planned; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 2: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for esophageal cancer: 1.18 ~ 70 years old; 2. Esophageal cancer surgery was planned after neoadjuvant chemotherapy; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 3: Clinical study on perioperative rapid recovery of patients with ovarian cancer after neoadjuvant chemotherapy using Shengmai decoction: 1.18 ~ 70 years old; 2. Neoadjuvant chemotherapy was followed by ovarian cancer surgery; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 4: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for gastric cancer: 1.18-70 years old; 2. Neoadjuvant chemotherapy was followed by gastric cancer surgery; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Sub-topic 5: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients with colorectal cancer after neoadjuvant chemotherapy: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, bowel cancer operation was proposed; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 6: Clinical study on the application of pulse-making drink to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for lung cancer: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, lung cancer surgery is planned; 3. Elective surger
Exclusion criteria
Exclusion criteria: 1. Allergic to the composition of drugs in Shengmai decoction; 2. Patients with unresectable tumors or distant metastases found during the operation; 3. Patients who had performed TCM treatment one month before hospitalization; 4. Patients with severe failure of heart, liver, kidney and other organs; 5. Pregnant and lactating women; 6. Suffering from mental illness, unable to communicate, unable to provide informed consent; 7. Patients or family members are unable to cooperate with or refuse to complete the quality of life score of cancer patients. The exclusion criteria for sub-topics are the same as above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life score, QOL,(The sub-project is the same as the major project); | — |
Secondary
| Measure | Time frame |
|---|---|
| First time out of bed(The sub-project is the same as the major project);Time of first exhaust(The sub-project is the same as the major project);Time of first feeding(The sub-project is the same as the major project);Time to first bowel movement((The sub-project is the same as the major project));Drain indwelling time(The sub-project is the same as the major project);Hospital stays((The sub-project is the same as the major project));myocardial enzyme(The sub-project is the same as the major project); | — |
Countries
China
Contacts
Cancer Hospital, Chinese Academy of Medical Sciences